Financial Information Show all Quarterly Results Show all 2022 Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update Recent Annual Reports Date Filed View Apr 29, 2022 0001104659-22-053710.pdf 0001104659-22-053710.rtf 0001104659-22-053710.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Mar 21, 2022 0001558370-22-004015.pdf 0001558370-22-004015.rtf 0001558370-22-004015.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML View more » Recent Proxy Statements Date Filed View Jul 21, 2022 0001104659-22-081604.pdf 0001104659-22-081604.rtf View HTML May 25, 2022 0001104659-22-064708.pdf 0001104659-22-064708.rtf 0001104659-22-064708.xls View HTML View more » SEC Filings Date Filed View Dec 19, 2022 View HTML 0001415889-22-012766.pdf 0001415889-22-012766.rtf 0001415889-22-012766.xls Dec 19, 2022 View HTML 0001104659-22-128310.pdf 0001104659-22-128310.rtf 0001104659-22-128310.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View more »
